55results about How to "Low background signal" patented technology

The present invention provides an oligonucleotide probe, which comprises an oligonucleotide molecule and a label bound to the oligonucleotide molecule, wherein the oligonucleotide molecule comprises: a hairpin capable of forming a hairpin structure A self-complementary region, a target nucleic acid recognition region, and a target nucleic acid recognition-like region, the label (a) providing a detectable signal when the probe is in a non-hybridizing form but having a reduced or substantially detectable signal when the probe hybridizes to a complementary nucleic acid Provides no detectable signal, or (b) provides a detectable signal when the probe hybridizes to a complementary nucleic acid, but provides a reduced or substantially no detectable signal when the probe is in non-hybridized form.

The invention discloses an hsa-miR-9 (Human Serum Albumin-Micro Ribonucleic Acid-9) detection kit and an hsa-miR-9 detection method based on AllGlo probe fluorescent quantitative PCR (Polymerase Chain Reaction) and relates to MicroRNA (Micro Ribonucleic Acid). The kit is provided with a kit body, a partition, an exogenous reference bottle, a stem-loop reverse transcription reagent bottle and a real-time fluorescent quantitative PCR reagent bottle. The detection method comprises the steps of extracting miRNA from a sample, adding 5 microliters of exogenous reference cel-miR-39 (Caenorhabditis Elegans-Micro Ribonucleic Acid-39) at a concentration of 5n mol provided by the kit after full lysis of the sample, and swirling and shaking in case of a sample of serum / plasma sample or other body fluids, adding no exogenous reference cel-miR-39 in case of a sample of a cell or a tissue, performing reverse transcription on miRNA to form cDNA (Complementary Deoxyribonucleic Acid) with a stem-loop reverse transcription reagent provided by the kit, performing real-time PCR amplification on cDNA with a real-time fluorescent quantitative PCR reagent provided by the kit, and setting a reasonable threshold and a baseline for result analysis by synthesizing various data given by an analytical instrument.

The invention relates to microRNA, particularly an hsa-miR-520a-3p detection kit based on AllGlo probe fluorescence quantitative PCR (polymerase chain reaction) and a detection method thereof. The kit is provided with a box body, partitions, an exogenous reference bottle, a stem-loop reverse transcription reagent bottle and a real-time fluorescence quantitative PCR reagent bottle. The method comprises the following steps: extracting miRNA (microribonucleic acid) in a sample, wherein if the sample is serum / plasma or any other body fluid, after the sample is sufficiently cracked, 5 mu L of 5n mol exogenous reference cel-miR-39 provided by the kit is added and vortex oscillation is performed, and if the sample is a cell or tissue sample, no exogenous reference cel-miR-39 is needed; carrying out real-time PCR amplification on the stem-loop reverse transcription reagent reverse transcription miRNA provided by the kit as cDNA (omplementary deoxyribonucleic acid) by using the real-time fluorescence quantitative PCR reagent provided by the kit; and setting reasonable thresholds and base lines according to data given by a comprehensive analysis instrument, and carrying out result analysis.

The invention discloses an hsa-miR-146 (Human Serum Albumin-Micro Ribonucleic Acid-146) detection kit and an hsa-miR-146 detection method based on AllGlo probe fluorescent quantitative PCR (Polymerase Chain Reaction) and relates to MicroRNA (Micro Ribonucleic Acid). The kit is provided with a kit body, a partition, an exogenous reference bottle, a stem-loop reverse transcription reagent bottle and a real-time fluorescent quantitative PCR reagent bottle. The detection method comprises the steps of extracting miRNA from a sample, adding 5 microliters of exogenous reference cel-miR-39 (Caenorhabditis Elegans-Micro Ribonucleic Acid-39) at a concentration of 5n mol provided by the kit after full lysis of the sample, and swirling and shaking in case of a sample of serum / plasma sample or other body fluids, adding no exogenous reference cel-miR-39 in case of a sample of a cell or a tissue, performing reverse transcription on miRNA to form cDNA (Complementary Deoxyribonucleic Acid) with a stem-loop reverse transcription reagent provided by the kit, performing real-time PCR amplification on cDNA with a real-time fluorescent quantitative PCR reagent provided by the kit, and setting a reasonable threshold and a baseline for result analysis by synthesizing various data given by an analytical instrument.